Primarily being a medical journal, JPMA publishes scholarly research focusing on the various fields in the areas of health and medical education. It publishes original research describing recent advances in health particularly clinical studies, clinical trials, assessments of pathogens of diagnostic importance, medical genetics and epidemiological studies. Review articles highlighting importance of various issues in the domain of public health, drug research and medical education are also accepted. As a leading journal of South Asia, JPMA remains cognizant of the recent advances in the rapidly growing fields of biomedical sciences, it invites and encourages scholars to write short reviews and invited editorials on the emerging issues. We particularly aim to promote health standards of developing countries by encouraging manuscript submissions on issues affecting the public health and health delivery services.

JPMA 主要是一本医学期刊，发表的学术研究侧重于健康和医学教育领域的各个领域。它发表原创研究，描述健康领域的最新进展，特别是临床研究、临床试验、诊断重要性病原体评估、医学遗传学和流行病学研究。它还接受强调公共卫生、药物研究和医学教育领域各种问题重要性的评论文章。作为南亚领先的期刊，JPMA 始终关注快速发展的生物医学科学领域的最新进展，它邀请并鼓励学者就新兴问题撰写简短的评论和特邀社论。我们特别致力于通过鼓励就影响公共卫生和医疗服务的问题提交手稿来促进发展中国家的健康标准。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映MEDICINE, GENERAL & INTERNAL-MEDICINE, RESEARCH & EXPERIMENTAL领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为0.8，平均审稿速度为 36 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。